Bausch + Lomb Corporation
BLCO
$17.73-0.31 (-1.72%)
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical.
StreetsValue research for Bausch + Lomb Corporation (BLCO)
Members get the full report for Bausch + Lomb Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.